Management of retroperitoneal high-grade serous carcinoma of unknown origin : A case report
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved..
BACKGROUND: Retroperitoneal high-grade serous carcinoma (HGSC) of unknown origin is a sporadic tumor that can originate from ovarian cancer. Herein, we report the case of a woman with retroperitoneal HGSC of unknown origin and describe how she was diagnosed and treated.
CASE SUMMARY: A 71-year-old female presented with the tumor marker CA125 elevated to 1041.9 U/mL upon a regular health examination. Computed tomography revealed retroperitoneal lymph node enlargement. Subsequently, positron emission tomography scanning revealed lesions with increased F-18 fluorodeoxyglucose uptake at the nodes. As a result, she underwent laparoscopic lymph node resection, and pathology revealed metastatic adenocarcinoma with CK7(+), PAX8(+), WT1(+), PR(-), and p53 mutational loss of expression, indicating that the origin may be from the adnexa. The patient was admitted to our ward and underwent laparoscopic staging; however, the pathological results were negative. Under the suspicion of retroperitoneal HGSC of unknown origin, chemotherapy and targeted therapy were initiated. Tumor marker levels decreased after treatment.
CONCLUSION: We present a case of HGSC of unknown origin managed using retroperitoneal lymphadenectomy, staging surgery, chemotherapy, and targeted therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
World journal of clinical cases - 12(2024), 6 vom: 26. Feb., Seite 1190-1195 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hsieh, Wen-Lin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Revised 12.03.2024 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.12998/wjcc.v12.i6.1190 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369546571 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369546571 | ||
003 | DE-627 | ||
005 | 20240312234424.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240311s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12998/wjcc.v12.i6.1190 |2 doi | |
028 | 5 | 2 | |a pubmed24n1324.xml |
035 | |a (DE-627)NLM369546571 | ||
035 | |a (NLM)38464925 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hsieh, Wen-Lin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Management of retroperitoneal high-grade serous carcinoma of unknown origin |b A case report |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
520 | |a BACKGROUND: Retroperitoneal high-grade serous carcinoma (HGSC) of unknown origin is a sporadic tumor that can originate from ovarian cancer. Herein, we report the case of a woman with retroperitoneal HGSC of unknown origin and describe how she was diagnosed and treated | ||
520 | |a CASE SUMMARY: A 71-year-old female presented with the tumor marker CA125 elevated to 1041.9 U/mL upon a regular health examination. Computed tomography revealed retroperitoneal lymph node enlargement. Subsequently, positron emission tomography scanning revealed lesions with increased F-18 fluorodeoxyglucose uptake at the nodes. As a result, she underwent laparoscopic lymph node resection, and pathology revealed metastatic adenocarcinoma with CK7(+), PAX8(+), WT1(+), PR(-), and p53 mutational loss of expression, indicating that the origin may be from the adnexa. The patient was admitted to our ward and underwent laparoscopic staging; however, the pathological results were negative. Under the suspicion of retroperitoneal HGSC of unknown origin, chemotherapy and targeted therapy were initiated. Tumor marker levels decreased after treatment | ||
520 | |a CONCLUSION: We present a case of HGSC of unknown origin managed using retroperitoneal lymphadenectomy, staging surgery, chemotherapy, and targeted therapy | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Case report | |
650 | 4 | |a Chemotherapy | |
650 | 4 | |a High-grade serous carcinoma | |
650 | 4 | |a Lymph node | |
650 | 4 | |a Origin | |
650 | 4 | |a Retroperitoneum | |
700 | 1 | |a Ding, Dah-Ching |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t World journal of clinical cases |d 2013 |g 12(2024), 6 vom: 26. Feb., Seite 1190-1195 |w (DE-627)NLM233331727 |x 2307-8960 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2024 |g number:6 |g day:26 |g month:02 |g pages:1190-1195 |
856 | 4 | 0 | |u http://dx.doi.org/10.12998/wjcc.v12.i6.1190 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2024 |e 6 |b 26 |c 02 |h 1190-1195 |